These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31561918)

  • 21. Extra-ocular retinoblastoma: about 12 cases followed at the Mohamed VI university hospital of Marrakech.
    Leila S; Ibtissam H; Hafsa E; Abdeljalil M
    Pan Afr Med J; 2016; 25():131. PubMed ID: 28292093
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Clinical features of retinoblastoma in Tunisia].
    Chebbi A; Bouguila H; Boussaid S; Ben Aleya N; Zgholi H; Malek I; Zeghal I; Nacef L
    J Fr Ophtalmol; 2014 Jun; 37(6):442-8. PubMed ID: 24792399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Retinoblastoma in Taiwan: survival and clinical characteristics 1978-2000.
    Kao LY; Su WW; Lin YW
    Jpn J Ophthalmol; 2002; 46(5):577-80. PubMed ID: 12457919
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RETINOBLASTOMA IN INDIA: Clinical Presentation and Outcome in 1,457 Patients (2,074 Eyes).
    Kaliki S; Patel A; Iram S; Ramappa G; Mohamed A; Palkonda VAR
    Retina; 2019 Feb; 39(2):379-391. PubMed ID: 29210937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Retinoblastoma in Taiwan: survival rate and prognostic factors.
    Chang CY; Chiou TJ; Hwang B; Bai LY; Hsu WM; Hsieh YL
    Jpn J Ophthalmol; 2006; 50(3):242-9. PubMed ID: 16767380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Study on clinical therapeutic effect including symptoms, eye preservation rate, and follow-up of 684 children with retinoblastoma.
    Huang D; Zhang Y; Zhang W; Wang Y; Zhang P; Hong L; Zhou Y; Han T; Zhi T
    Eur J Ophthalmol; 2013; 23(4):532-8. PubMed ID: 23483499
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sonographic, CT, and MR imaging findings in diffuse infiltrative retinoblastoma: report of two cases with histologic comparison.
    Brisse HJ; Lumbroso L; Fréneaux PC; Validire P; Doz FP; Quintana EJ; Berges O; Desjardins LC; Neuenschwander SG
    AJNR Am J Neuroradiol; 2001 Mar; 22(3):499-504. PubMed ID: 11237973
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of advanced uni- or bilateral retinoblastoma with macroscopic optic nerve invasion.
    Choucair ML; Brisse HJ; Fréneaux P; Desjardins L; Dorfmüller G; Puget S; Dendale R; Chevrier M; Doz F; Lumbroso-Le Rouic L; Aerts I
    Pediatr Blood Cancer; 2020 Jan; 67(1):e27998. PubMed ID: 31571399
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical misdiagnosis of retinoblastoma in Indian children.
    Chawla B; Khurana S; Sen S; Sharma S
    Br J Ophthalmol; 2014 Apr; 98(4):488-93. PubMed ID: 24457360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Presenting signs of retinoblastoma in Congolese patients.
    Kaimbo WK; Mvitu MM; Missotten L
    Bull Soc Belge Ophtalmol; 2002; (283):37-41. PubMed ID: 12058485
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CT and MRI features of recurrent tumors and second primary neoplasms in pediatric patients with retinoblastoma.
    Tateishi U; Hasegawa T; Miyakawa K; Sumi M; Moriyama N
    AJR Am J Roentgenol; 2003 Sep; 181(3):879-84. PubMed ID: 12933497
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Retinoblastoma update].
    Aerts I; Lumbroso-Le Rouic L; Gauthier-Villars M; Brisse H; Doz F
    Arch Pediatr; 2016 Jan; 23(1):112-6. PubMed ID: 26679524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical Predictors at Diagnosis of Low-Risk Histopathology in Unilateral Advanced Retinoblastoma.
    Kletke SN; Feng ZX; Hazrati LN; Gallie BL; Soliman SE
    Ophthalmology; 2019 Sep; 126(9):1306-1314. PubMed ID: 30986443
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical pathologic study of a cohort of patients with retinoblastoma from a developing country.
    Orellana ME; Fernandes BF; Arean C; Pifano I; Al-Kandari A; Burnier MN
    J Pediatr Ophthalmol Strabismus; 2009; 46(5):294-9. PubMed ID: 19791727
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Some clinical findings at presentation can predict high-risk pathology features in unilateral retinoblastoma.
    Chantada GL; Gonzalez A; Fandino A; de Davila MT; Demirdjian G; Scopinaro M; Abramson D
    J Pediatr Hematol Oncol; 2009 May; 31(5):325-9. PubMed ID: 19415010
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Retinoblastoma: a recent experience at the National University Hospital, Singapore.
    Aung L; Chan YH; Yeoh EJ; Tan PL; Quah TC
    Ann Acad Med Singap; 2009 Aug; 38(8):693-8. PubMed ID: 19736573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presenting signs of retinoblastoma at a tertiary level teaching hospital in Ethiopia.
    Shifa JZ; Gezmu AM
    Pan Afr Med J; 2017; 28():66. PubMed ID: 29230267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and epidemiological characteristics of retinoblastoma: correlation with prognosis in a Turkish pediatric oncology center.
    Ozdemir H; Tacyildiz N; Unal E; Yavuz G; Ugur H; Gunduz K
    Pediatr Hematol Oncol; 2007; 24(3):221-31. PubMed ID: 17454793
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is screening for primitive neuroectodermal tumors in patients with unilateral retinoblastoma necessary?
    Ibarra MS; O'Brien JM
    J AAPOS; 2000 Feb; 4(1):54-6. PubMed ID: 10675872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MRI of retinoblastoma.
    Razek AA; Elkhamary S
    Br J Radiol; 2011 Sep; 84(1005):775-84. PubMed ID: 21849363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.